AstraZeneca’s expanding footprint in the US includes, among others: A state-of-the-art R&D centre in Kendall Square, Cambridge, Massachusetts; A next generation manufacturing facility for biologics in ...
The new investments will expand manufacturing sites in Maryland, Texas and California. But AstraZeneca shares have fallen nearly 6% this year, underperforming a near 9% rise in the wider European ...
many of the projects AstraZeneca outlined are, in fact, not exactly new. For instance, the company announced plans for its cell therapy facility in Rockville, Maryland back in February.
AstraZeneca has announced a major expansion ... spend $2bn to bolster its manufacturing capacity in states including Maryland and Texas as well as on the west coast. This would bring its total ...
(RTTNews) - British drug maker AstraZeneca Plc (AZN.L ... a next generation manufacturing facility for biologics in Maryland; Cell therapy manufacturing capacity on the West and East Coasts ...
AstraZeneca made headlines for several reasons on Tuesday ... The investment will also support creation of a new next generation manufacturing facility, focused on biologics, in Maryland as well as ...